Top compounds associated with response to DYRK2


Feature Type Standardized
Nominal ANOVA
mRNA paclitaxel GDSC1000 pan-cancer AAC 0.00049 1
mRNA Topotecan CCLE pan-cancer AAC 0.00041 1
mRNA purmorphamine CTRPv2 pan-cancer AAC -0.0003 1
mRNA Vandetanib CCLE pan-cancer AAC 0.00032 1
mRNA Imatinib GDSC1000 pan-cancer AAC 0.00018 1
mRNA UNC0321 CTRPv2 pan-cancer AAC 5.1e-05 1
Download CSV